Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Effect of Chemotherapy-induced Peripheral Neuropathy (CIPN) on Sensory and Motor Function in Patients With Cancer

NCT04799080 is registered in ClinicalTrials.gov with Izmir Bakircay University as lead sponsor.

NCT NCT04799080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Effect of Chemotherapy-induced Peripheral Neuropathy (CIPN) on Sensory and Motor Function in Patients With Cancer
Lead sponsor
Izmir Bakircay University
Phase
Observational
Overall status
Completed
Start date
March 6, 2021
Completion date
May 15, 2022
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, cancer, chemotherapeutic toxicity, chemotherapy-induced peripheral neuropathy, colo-rectal cancer, colon neoplasm